[Featured Stock] Three Billion Soars Over 20%... Surpasses 7,000 Won Intraday
The stock price of Three Billion, an AI-based genetic disease diagnostic testing company, is showing a strong gain of over 20%.
As of 2:12 PM on the 17th, just before the market close, Three Billion's stock is trading at 6,970 KRW per share, up 22.93% compared to the previous trading day. During the session, the price briefly surpassed 7,000 KRW per share.
This surge is attributed to the news that the company signed a memorandum of understanding (MOU) for genetic testing cooperation with Korea AstraZeneca before the market opened, which triggered buying interest.
Hot Picks Today
"Even Luxury Cars Drive Off Without Paying"... ...
- "Only the Top 1% Winning Big in Stocks Smile... '300 Million Won Splurges' or '1...
- Applied Just for Skin Soothing...Study Finds It Suppresses Antibiotic Resistance
- "Is the Starting Salary Really 4 Million Won?"... Surprise as Navy Salary and Sa...
- “Nothing Left to Protect” as Japan Drops Its “Peace State” Banner... Lifts B...
Through this collaboration, Three Billion and AstraZeneca plan to establish a genetic testing system capable of completing diagnosis within two weeks for patients with atypical hemolytic uremic syndrome (aHUS), a rare disease.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.